Campbell D J
Laboratory of Molecular Endocrinology, Massachusetts General Hospital, Boston.
J Cardiovasc Pharmacol. 1987;10 Suppl 7:S1-8. doi: 10.1097/00005344-198706107-00002.
The classical concept of the renin-angiotensin system as an endocrine system, whereby angiotensin is generated in the circulation and conveyed by blood to peripheral tissues, is being increasingly challenged by evidence that suggests that peripheral tissues are the major site of generation of angiotensin I and II. The concentrations of angiotensins I and II in arterial and venous blood, taken together with their efficient metabolic clearance by peripheral tissues and their slow rate of generation in blood, indicate that peripheral tissues are the major site of generation of these peptides. Most angiotensin I and II in blood is generated within tissues by the action of plasma-derived renin on plasma-derived angiotensinogen, and the action of tissue converting enzyme. In addition, there is increasing evidence for the synthesis of renin by tissues other than the kidney, and of angiotensinogen by tissues other than the liver. The relative contribution of plasma renin and angiotensinogen, and of locally synthesized renin (or renin-like enzyme) and angiotensinogen, to angiotensin generation in each tissue is unknown, and probably differs between tissues. These two mechanisms for local generation of angiotensin within tissues have the potential to produce changes in tissue concentrations of angiotensin that are independent of the circulating level of renin and angiotensin.
肾素 - 血管紧张素系统作为一种内分泌系统的经典概念,即血管紧张素在循环中生成并通过血液输送到外周组织,正日益受到证据的挑战,这些证据表明外周组织是血管紧张素I和II的主要生成部位。动脉血和静脉血中血管紧张素I和II的浓度,连同外周组织对它们的有效代谢清除以及它们在血液中缓慢的生成速率,表明外周组织是这些肽的主要生成部位。血液中的大多数血管紧张素I和II是由血浆来源的肾素作用于血浆来源的血管紧张素原以及组织转化酶的作用在组织内生成的。此外,越来越多的证据表明,除肾脏外的其他组织可合成肾素,除肝脏外的其他组织可合成血管紧张素原。血浆肾素和血管紧张素原,以及局部合成的肾素(或肾素样酶)和血管紧张素原对每个组织中血管紧张素生成的相对贡献尚不清楚,并且可能因组织而异。组织内血管紧张素的这两种局部生成机制有可能产生与肾素和血管紧张素的循环水平无关的组织中血管紧张素浓度变化。